Knott David M Jr »

Relmada Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 439k 6.96
2021-12-31 $135k 6.0k 22.50

More positions owned by Knott David M Jr

Alphabet Inc-Cl C Common (GOOG)
Apollo Global Management Common (APO)
Syndax Pharmaceutical Common (SNDX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
Xeris Biopharma Holdings Common (XERS)
JPMorgan Chase & Co. Common (JPM)
Iovance Biotherapeutics Common (IOVA)
LPL Financial Holdings Common
Janus Henderson AAA CLO ETF Common (JAAA)
Alkermes Common (ALKS)
Travere Therapeutics Common (TVTX)
Cogent Biosciences Common (COGT)
Viridian Therapeutics Common (VRDN)
Agios Pharmaceutical Common (AGIO)

View all positions for Knott David M Jr

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Marshall Wace
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management

View all funds holding Relmada Therapeutics